On August 11, 2026, the Trump administration finalized a rule prohibiting federal Medicaid and CHIP funding for hormone therapy, puberty blockers, and surgeries for transgender youth under 19. Hospitals halted such services, leaving intersex and transgender minors without critical treatment.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
The Trump administration on Tuesday finalized a plan to cut off federal Medicaid funding for hormone therapy, puberty blockers and surgeries for transgender youths. Why it matters: The rule is the latest escalation in the administration's effort to limit transition-related care , which has tested the boundaries of executive powers and could undercut federal and state protections. States may still
Intersex kids are getting caught in the crosshairs of the Trump administration’s quest to deny gender-affirming care to minors. Hospitals halting gender-affirming care under Trump administration pressure are cutting off trans minors and intersex youth who depend on hormone therapy too.
ICYMI: On Tuesday, August 11th, the Trump administration published a final rule prohibiting the coverage of puberty-pausing medications, hormone therapy, and surgeries with federal Medicaid funds for people under 18... Here’s what you need to know about Trump’s ruling on gender-affirming care, and what you can do to support LGBTQ+ rights and access to life-saving healthcare.
this outlet adds: children, health, insurance, program, chip, read, join, list